Brief ReportsUsefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation
References (13)
- et al.
J Am Coll Cardiol
(1996) - et al.
Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation. A placebo-controlled study
J Am Coll Cardiol
(1996) - et al.
Electrical cardioversion after amiodarone administration
Am Heart J
(1992) - et al.
Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation
Circulation
(1996) - et al.
Pharmacologic enhancement of atrial electrical defibrillation efficacyrole of ibutilide
J Interv Electrophysiol
(1997) Transthoracic cardioversion of atrial fibrillation and flutterstandard techniques and new advances
J Am Cardiol
(1996)
Cited by (30)
Atrial Fibrillation: Antiarrhythmic Therapy
2014, Current Problems in CardiologyCitation Excerpt :Ibutilide pretreatment with 1 mg before transthoracic cardioversion increased the restoration of SR from 72%-100%.55 Ibutilide allowed cardioversion in 92%-100% of patients who failed electrical cardioversion and reduced the mean energy required.55,56 Ibutilide at this dose also demonstrated decreased AF recurrence compared with verapamil, and similar efficacy as amiodarone following pulmonary vein isolation.57,58
Managing arrhythmias in the intensive care unit
2014, Critical Care ClinicsCitation Excerpt :The risk of torsades de pointes is higher (and should therefore be avoided) in patients with heart failure, prolonged QT interval at baseline, or hypokalemia.34 Ibutilide can facilitate electrical cardioversion, but this has not been specifically tested in the ICU setting.35 Amiodarone is often the preferred agent in the ICU setting, particularly in patients with depressed ejection fractions given its better safety profile in this population.
Which therapy for which condition?
2013, Drugs for the Heart: Expert Consult - Online and Print2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
2011, Journal of the American College of CardiologyCitation Excerpt :After cardioversion to sinus rhythm, patients receiving drugs that prolong the QT interval should be monitored in the hospital for 24 to 48 h to evaluate the effects of heart rate slowing and allow for prompt intervention in the event torsades de pointes develops. In randomized studies of direct-current cardioversion, patients pretreated with ibutilide were more often converted to sinus rhythm than untreated controls, and those in whom cardioversion initially failed could more often be converted when the procedure was repeated after treatment with ibutilide (556,718). Ibutilide was more effective than verapamil in preventing immediate recurrence of AF (705).
Which Therapy for Which Condition?
2008, Drugs for the Heart: Expert Consult - Online and PrintAmerican College of Cardiology/American Heart Association 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion. A Report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the Heart Rhythm Society
2006, Journal of the American College of Cardiology